Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

MCKESSON CORPORATION (MCK)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

McKesson Corporation : McKesson and Epic Settle Patent Infringement Litigation

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/04/2013 | 08:11pm CEST


Settlement allows companies to focus on needs of customers

SAN FRANCISCO, March 4, 2013 - McKesson Corporation and Epic Systems Corporation have settled their longstanding patent infringement litigation involving McKesson's U.S. patent #6,757,898 and Epic's MyChart software. 

Under terms of the settlement, McKesson agreed to grant Epic a license to the patent for the benefit of Epic and its customers.  In exchange, Epic agreed that it will no longer contest the validity of the patent, allowing McKesson and Epic to return to normalcy in their relationship going forward.  The parties also agreed to dismiss all pending claims and counterclaims and end any further litigation and appeals.

Executives from both parties recognized the settlement as one that will benefit the healthcare industry in general, and allow both parties to focus on the needs of their customers. 

"We're delighted to have settled this litigation with McKesson," said Carl Dvorak, chief operating officer, Epic Systems Corporation.

"We look forward to reestablishing our prior relationship and exploring new opportunities to serve our mutual customers," echoed Jeff Felton, president of McKesson's RelayHealth business. "Both companies will benefit by putting this litigation behind us."

About McKesson Corporation

McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services.www.mckesson.com.

PR Contact

Kris Fortner
415.983.8352
kris.fortner@mckesson.com



distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MCKESSON CORPORATION
08/15MCKESSON : 4 Ways to Ensure Your Biopharmaceutical Drug Succeeds
PU
08/09MCKESSON : Appoints Brian Tyler as President and Chief Operating Officer
AQ
08/09EKF DIAGNOSTICS : 1st Half Slightly Ahead of Expectations, Signs U.S. Distributi..
DJ
08/07MCKESSON : Appoints Brian Tyler as President and Chief Operating Officer
AQ
08/06MCKESSON : 5 MIPS Tips for Your Specialty Practice in 2018
PU
08/06COMPUTER ASSISTED CODING SOFTWARE MA : The report includes a thorough overview o..
AQ
08/03MCKESSON CORPORATION : Report
CO
08/02MCKESSON : Reports Fiscal 2019 First-Quarter Results
AQ
08/01MCKESSON : Appoints Tyler As President, Chief Operating Officer
AQ
08/01MCKESSON CORPORATION : Report
CO
More news
News from SeekingAlpha
08/14Tracking Seth Klarman's Baupost Group Holdings - Q2 2018 Update 
08/13Broyhill Asset Management Mid-Year Letter 2018 
08/12S&P 500 : It's All In The Numbers And The Numbers Never Lie 
08/09Express Scripts leading drug wholesalers/PBMs in the green, up 3% 
08/09Global Payments To Acquire AdvancedMD For Healthcare Tech 
Financials ($)
Sales 2019 215 B
EBIT 2019 3 682 M
Net income 2019 1 616 M
Debt 2019 4 560 M
Yield 2019 1,13%
P/E ratio 2019 15,81
P/E ratio 2020 11,70
EV / Sales 2019 0,14x
EV / Sales 2020 0,13x
Capitalization 25 307 M
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 148 $
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
John H. Hammergren Chairman & Chief Executive Officer
Brian Scott Tyler President & Chief Operating Officer
Britt Vitalone Chief Financial Officer & Executive Vice President
Kathleen D. McElligott Chief Technology & Information Officer, EVP
M. Christine Jacobs Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION-18.94%25 307
CVS HEALTH CORPORATION-1.54%70 657
WALGREENS BOOTS ALLIANCE-5.36%65 976
EXPRESS SCRIPTS HOLDING CO16.09%47 238
AMERISOURCEBERGEN-7.30%17 971
CARDINAL HEALTH-17.99%15 242